| Literature DB >> 30037445 |
Erica M Simon1, Matthew J Streitz2, Daniel J Sessions3, Colin G Kaide4.
Abstract
Today a variety of anticoagulants and antiplatelet agents are available on the market. Given the propensity for bleeding among patients prescribed these medications, the emergency medicine physician must be equipped with a working knowledge of hemostasis, and anticoagulant and antiplatelet reversal. This article reviews strategies to address bleeding complications occurring secondary to warfarin, low-molecular-weight heparin, and direct oral anticoagulant therapy.Entities:
Keywords: Anticoagulant reversal; Heparin; Idarucizumab; Novel oral anticoagulants; Prothrombin complex concentrate; Warfarin
Mesh：
Substances：
Year: 2018 PMID： 30037445 DOI： 10.1016/j.emc.2018.04.014
Source DB: PubMed Journal: Emerg Med Clin North Am ISSN： 0733-8627 Impact factor: 2.264